Edwards Lifesciences (EW) Change in Receivables (2009 - 2026)
Edwards Lifesciences (EW) posted quarterly Change in Receivables of $117.9 million for Q1 2026, up 169.79% year-over-year from $43.7 million in Q1 2025, and up 463.89% quarter-over-quarter from -$32.4 million in Q4 2025.
Edwards Lifesciences (EW) Change in Receivables (2009 - 2026) Analysis & Trends
Edwards Lifesciences' Change in Receivables history runs 18 years deep, the most recent figure standing at $117.9 million for Q1 2026.
- In Q1 2026, Change in Receivables rose 169.79% year-over-year to $117.9 million; the TTM figure through Mar 2026 stood at $97.2 million (up 173.36% YoY), while the FY2025 annual figure was $23.0 million, up 118.98% from the prior year.
- Change in Receivables for Q1 2026 stood at $117.9 million, up from -$32.4 million in the prior quarter.
- The five-year high for Change in Receivables was $117.9 million in Q1 2026, with the low at -$105.9 million in Q4 2024.
- The 5-year median for Change in Receivables is $18.2 million (2023), against an average of $14.4 million.
- The sharpest annual moves came in 2023 and 2024: Change in Receivables jumped 1554.55% in 2023, then sank 3538.46% in 2024.
- Edwards Lifesciences' Change in Receivables stood at $1.1 million in 2022, then soared by 1554.55% to $18.2 million in 2023, then plunged by 681.87% to -$105.9 million in 2024, then surged by 69.41% to -$32.4 million in 2025, then jumped by 463.89% to $117.9 million in 2026.
- Business Quant data shows EW's Change in Receivables at $117.9 million in Q1 2026, -$32.4 million in Q4 2025, and -$13.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 129.50 Bn | 126.03 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 119.85 Bn | 110.63 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 73.79 Bn | 73.25 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.58 Bn | 32.64 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 34.14 Bn | 32.03 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | - |
| 9 | Steris | 23.23 Bn | 22.74 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Zimmer Biomet Holdings | 19.35 Bn | 18.94 Bn | 1.54 Bn | 38.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.20 Mn |
| Jun 30, 2026 | 10.20 Mn |
| Mar 31, 2026 | 117.90 Mn |
| Mar 31, 2026 | 117.90 Mn |
| Dec 31, 2025 | -32.40 Mn |
| Dec 31, 2025 | -32.40 Mn |
| Sep 30, 2025 | -13.20 Mn |
| Sep 30, 2025 | -13.20 Mn |
| Jun 30, 2025 | 24.90 Mn |
| Jun 30, 2025 | 24.90 Mn |
| Mar 31, 2025 | 43.70 Mn |
| Mar 31, 2025 | 43.70 Mn |
| Dec 31, 2024 | -105.90 Mn |
| Dec 31, 2024 | -105.90 Mn |
| Sep 30, 2024 | -47.30 Mn |
| Sep 30, 2024 | -47.30 Mn |
| Jun 30, 2024 | -23.00 Mn |
| Jun 30, 2024 | -23.00 Mn |
| Mar 31, 2024 | 55.00 Mn |
| Mar 31, 2024 | 55.00 Mn |